A Study of Early Cancer Detection in People at High Risk of Developing Pancreatic Ductal Adenocarcinoma (PDAC)
Conditions: Pancreatic Cyst Interventions: Diagnostic Test: 89Zr-DFO-HuMab-5B1 immunoPET; Diagnostic Test: HP MRI; Combination Product: Blood assay Sponsors: Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Pancreas | Pancreatic Cancer | Research | Study